• Corporate
• Start-Ups & Emerging Growth Companies
• Finance
• Venture Capital & Private Equity
• International
• Real Estate

2008 Deals Ad
2007 Deals Ad
2006 Deals Ad
2005 Deals Ad

Legal & Business Issues In the World of Pharmaceuticals

Attorney Josef Volman and Glenn Cooper, former Chairman and CEO of Indevus Pharmaceuticals, review the Indevus acquisition - a $750 million tender offer deal completed in early 2009.

Listen to podcast >>

Completion of its Acquisition (Approx. $370 Million Up Front and up to $267 Million of Future Contingent Payments) by Endo Pharmaceuticals Holdings Inc. (Nasdaq: ENDP)